The Latest

  • Image attribution tooltip
    Jack Taylor via Getty Images

    Pharma M&A stagnated in 2021 — here's what could help it rebound

    There are plenty of reasons pharma could get its M&A groove back in 2022.

  • Image attribution tooltip
    Permission granted by Copyright: <a href='https://www.123rf.com/profile_ileezhun'>ileezhun</a>

    Biote CEO breaks down barriers in women's health

    Women’s health is coming into sharper focus in 2022, but getting funding is still difficult.

  • Image attribution tooltip
    Spencer Platt via Getty Images
    Opinion

    Pharma execs reveal the industry's most pressing issues

    Several market factors — including COVID — are driving changes and trends in the industry.

  • Image attribution tooltip
    Diego Camargo/PharmaVoice

    Welcome to the new PharmaVoice

    A similar mission, a new format, and our plans for PharmaVoice's next chapter.

  • Image attribution tooltip
    Diego Camargo/PharmaVoice
    Podcast

    Woman of the Week Podcast: Astrid DeFries-Lansing

    Astrid DeFries-Lansing, EVP, Executive Creative Director, GSW, powered by Syneos Health, who believes creativity is an attitude not simply a skill set, speaks to her approach in developing campaigns that speak to human truths, are beautiful, and resonate with audiences.

  • Image attribution tooltip
    Diego Camargo/PharmaVoice

    PharmaVoice 100 Nomination Form

    Recognition for the most inspiring people in the life-sciences industry, as determined by our readers.

  • Image attribution tooltip
    Diego Camargo/PharmaVoice
    Podcast

    Woman of the Week Podcast: Marie Lamont

    Marie Lamont, General Manager of Inteliquet, shares her insights on why clinical trials as a care option is so important, how to employ creative tension to build high-performing teams, and how to thoughtfully and purposefully build a network can lead to career success.

  • Image attribution tooltip
    [photo]. Retrieved from Google image.

    Rare disease innovation in 2022

    More companies are targeting gene therapies for rare disease treatments.

  • Image attribution tooltip
    Diego Camargo/PharmaVoice
    Podcast

    Woman of the Week Podcast: Barbara Krebs-Pohl, Ph.D.

    Dr. Barbara Krebs-Pohl, SVP, Head of Global BD&L and Alliance Management of MorphoSys, shares her extraordinary scientific journey from academia to business, including in-licensing and M&A, all with the goal of cures in mind for cancer.